Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
Abstract
ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options. Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information ( Appendix 1 and Appendix 2 , online only) .
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (17)
Humera Khurshid
Division of Hematology and Oncology Department of Medicine Warren Alpert School of Medicine Brown University Providence Rhode Island USA
Nofisat Ismaila
American Society of Clinical Oncology (ASCO), Alexandria, VA, US
Jessica Bian
Raetasha Dabney
Texas Oncology, Grapevine, TX
Millie Das
Peter Ellis
Jill Feldman
Patient Advocate EGFR Resisters Deerfield Illinois USA
Christine L. Hann
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD
Swati Kulkarni
Windsor Regional Cancer Program/Western University, Windsor, ON, Canada
Janessa Laskin
Rami Manochakian
Mayo Clinic Florida, Jacksonville, FL
Deebya Raj Mishra
BP Koirala Institute of Health Sciences, Dharan, Nepal
Isabel Preeshagul
Pavan Reddy
16Baylor Cancer Center, Houston, United States
Ashish Saxena
Frank Weinberg
University of Illinois College of Medicine at Chicago, Division of Hematology and Oncology, Chicago, IL
Gregory P. Kalemkerian
Department of Medicine, Hematology-Oncology, University of Michigan, Ann Arbor, MI